Relationship of lipid regulatory gene polymorphisms and dyslipidemia in a pediatric population: the CASPIAN III study

Juhola J, Magnussen CG, Viikari JS, Kähönen M, Hutri-Kähönen N, Jula A et al (2011) Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study. J Pediatr 159(4):584–590 Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL (2015) Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999–2012. JAMA Pediatr 169(3):272–279 Hovsepian S, Kelishadi R, Djalalinia S, Farzadfar F, Naderimagham S, Qorbani M (2015) Prevalence of dyslipidemia in Iranian children and adolescents: a systematic review. J Res Med Sci: off J Isfahan Univ Med Sci 20(5):503 Ordovas JM (2006) Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 106(7):1074–1081 Cole CB, Nikpay M, McPherson R (2015) Gene–environment interaction in dyslipidemia. Curr Opin Lipidol 26(2):133–138 Parnell LD (2009) Gene–environment interactions and the impact on obesity and lipid profile phenotypes. Clin Lipidol 4(6):687–690 Talmud PJ, Berglund L, Hawe EM, Waterworth DM, Isasi CR, Deckelbaum RE et al (2001) Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics 108(3):e50 Latsuzbaia A, Jaddoe VW, Hofman A, Franco OH, Felix JF (2016) Associations of genetic variants for adult lipid levels with lipid levels in children. The Generation R Study. J Lipid Res 57(12):2185–2192 Christie S, Robiou-du-Pont S, Anand SS, Morrison KM, McDonald SD, Paré G et al (2017) Genetic contribution to lipid levels in early life based on 158 loci validated in adults: the FAMILY study. Sci Rep 7 Santos IR, Fernandes AP, Sousa MO, Ferreira CN, Gomes KB (2013) Genetic polymorphisms as a risk factor for dyslipidemia in children. J Pediatr Genet 2(2):69–75 Ellman N, Keswell D, Collins M, Tootla M, Goedecke JH (2015) Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women. Atherosclerosis 240(2):311–317 Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316(5829):1331–1336 Uyeda K, Repa JJ (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 4(2):107–110 Nakayama K, Bayasgalan T, Tazoe F, Yanagisawa Y, Gotoh T, Yamanaka K et al (2010) A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle. Hum Genet 127(6):685–690 Kelishadi R, Heshmat R, Motlagh ME, Majdzadeh R, Keramatian K, Qorbani M et al (2012) Methodology and early findings of the third survey of CASPIAN study: a national school-based surveillance of students’ high risk behaviors. Int J Prev Med 3(6):394 Zimmet P, Alberti G, Kaufman F, Tajima N (2007) The metabolic syndrome in children and adolescents. Lancet 369(9579):2059 Li J, Motsko SP, Goehring EL, Tave A, Pezzullo JC, Jones JK (2010) Prevalence of pediatric dyslipidemia: comparison of a population-based claims database to national surveys. Pharmacoepidemiol Drug Saf 19(10):1031–1040 Faria Neto JR, Bento VFR, Baena CP, Olandoski M, Gonçalves LGO, Abreu GA et al (2016) ERICA: prevalence of dyslipidemia in Brazilian adolescents. Rev Saude Publica 50 Yang S, Hwang JS, Park HK, Lee HS, Kim HS, Kim EY et al (2012) Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007–2009). PLoS One 7(12):e49253 Al-Shehri SN, Saleh ZA, Salama MM, Hassan YM (2004) Prevalence of hyperlipidemia among Saudi school children in Riyadh. Ann Saudi Med 24(1):6–8 Rerksuppaphol S, Rerksuppaphol L (2011) Prevalence of dyslipidemia in Thai schoolchildren. J Med Assoc Thail 94(6):710 Middelberg RP, Heath AC, Madden PA, Montgomery GW, Martin NG, Whitfield JB (2012) Evidence of differential allelic effects between adolescents and adults for plasma high-density lipoprotein. PloSone 7(4):e35605 Johansen CT, Kathiresan S, Hegele RA (2011) Genetic determinants of plasma triglycerides. J Lipid Res 52(2):189–206 Hadarits F, Kisfali P, Mohás M, Maász A, Duga B, Janicsek I et al (2012) Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients. Mol Biol Rep 39(2):1949–1955 Surakka I, Horikoshi M, Mägi R, Sarin A-P, Mahajan A, Lagou V et al (2015) The impact of low-frequency and rare variants on lipid levels. Nat Genet 47(6):589–597 Shang X, Song J, Liu F, Ma J, Wang H (2014) Association between rs780094 polymorphism in GCKR and plasma lipid levels in children and adolescents. Zhonghua Liu Xing Bing Xue Za Zhi 35(6):626–629 Horvatovich K, Bokor S, Polgar N, Kisfali P, Hadarits F, Jaromi L et al (2011) Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children. Diabetes Metab 37(5):432–439 Lee H-J, Jang HB, Kim H-J, Ahn Y, Hong K-W, Cho SB et al (2015) The dietary monounsaturated to saturated fatty acid ratio modulates the genetic effects of GCKR on serum lipid levels in children. Clin Chim Acta 450:155–161 Sparsø T, Andersen G, Nielsen T, Burgdorf K, Gjesing A, Nielsen A et al (2008) The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51(1):70–75 Sotos-Prieto M, Luben R, Khaw K-T, Wareham NJ, Forouhi NG (2014) The association between Mediterranean Diet Score and glucokinase regulatory protein gene variation on the markers of cardiometabolic risk: an analysis in the European Prospective Investigation into Cancer (EPIC)-Norfolk study. Br J Nutr 112(1):122–131 Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S et al (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30(11):2264–2276 Shen Y, Wu L, Xi B, Liu X, Zhao X, Cheng H et al (2013) GCKR variants increase triglycerides while protecting from insulin resistance in Chinese children. PLoS One 8(1):e55350 Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR et al (2008) Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 40(2):149–151 Nakayama K, Yanagisawa Y, Ogawa A, Ishizuka Y, Munkhtulga L, Charupoonphol P et al (2011) High prevalence of an anti-hypertriglyceridemic variant of the MLXIPL gene in Central Asia. J Hum Genet 56(12) Been LF, Nath SK, Ralhan SK, Wander GS, Mehra NK, Singh J et al (2010) Replication of association between a common variant near melanocortin-4 receptor gene and obesity-related traits in Asian Sikhs. Obesity 18(2):425–429 Vrablik M, Ceska R, Adamkova V, Peasey A, Pikhart H, Kubinova R et al (2008) MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Hum Genet 124(5):553–555 Polgár N, Járomi L, Csöngei V, Maász A, Sipeky C, Sáfrány E et al (2010) Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke. Eur J Neurol 17(8):1033–1039 Kelishadi R, Motlagh ME, Roomizadeh P, Abtahi S-H, Qorbani M, Taslimi M et al (2013) First report on path analysis for cardiometabolic components in a nationally representative sample of pediatric population in the Middle East and North Africa (MENA): the CASPIAN-III Study. Ann Nutr Metab 62(3):257–265 Lattka E, Illig T, Koletzko B, Heinrich J (2010) Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 21(1):64–69 Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE et al (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41(1):56–65 Standl M, Lattka E, Stach B, Koletzko S, Bauer C-P, von Berg A et al (2012) FADS1 FADS2 gene cluster, PUFA intake and blood lipids in children: results from the GINIplus andLISAplus studies. PLoS One 7(5):e37780 Moltó-Puigmartí C, Jansen E, Heinrich J, Standl M, Mensink RP, Plat J et al (2013) Genetic variation in FADS genes and plasma cholesterol levels in 2-year-old infants: KOALA Birth Cohort Study. PLoS One 8(5):e61671 Garcés C, de Oya I, Lasunción MA, López-Simón L, Cano B, de Oya M (2010) Sex hormone–binding globulin and lipid profile in pubertal children. Metabolism 59(2):166–171 Aydın B, Winters SJ (2016) Sex hormone-binding globulin in children and adolescents. J Clin Res Pediatr Endocrinol 8(1):1 Niroumand S, Dadgarmoghaddam M, Eghbali B, Abrishami M, Gholoobi A, Taghanaki HRB et al (2016) Cardiovascular disease risk factors profile in individuals with diabetes compared with non-diabetic subjects in north-east of Iran. Iran Red Crescent Med J 18(8):e29382 Khajedaluee M, Dadgarmoghaddam M, Saeedi R, Izadi-Mood Z, Abrishami M (2014) The burden of diabetes in a developing country. Open J Prev Med 4(04):175 Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14